GE HealthCare announces cash dividend for first quarter of 2025
GE HealthCare Technologies (Nasdaq: GEHC) has announced its quarterly dividend payment for Q1 2025. The company's Board of Directors has declared a cash dividend of $0.035 per share of Common Stock. The dividend will be paid on May 15, 2025, to shareholders who are on record as of April 25, 2025.
GE HealthCare Technologies (Nasdaq: GEHC) ha annunciato il pagamento del dividendo trimestrale per il primo trimestre del 2025. Il Consiglio di Amministrazione dell'azienda ha dichiarato un dividendo in contante di $0.035 per azione di azioni ordinarie. Il dividendo sarà pagato il 15 maggio 2025 agli azionisti registrati entro il 25 aprile 2025.
GE HealthCare Technologies (Nasdaq: GEHC) ha anunciado el pago de su dividendo trimestral para el primer trimestre de 2025. La Junta Directiva de la compañía ha declarado un dividendo en efectivo de $0.035 por acción de acciones ordinarias. El dividendo se pagará el 15 de mayo de 2025 a los accionistas que estén registrados hasta el 25 de abril de 2025.
GE HealthCare Technologies (Nasdaq: GEHC)는 2025년 1분기 분기 배당금 지급을 발표했습니다. 회사 이사회는 보통주 1주당 $0.035의 현금 배당금을 선언했습니다. 배당금은 2025년 5월 15일에 지급되며, 2025년 4월 25일 기준으로 주주에게 지급됩니다.
GE HealthCare Technologies (Nasdaq: GEHC) a annoncé le paiement de son dividende trimestriel pour le premier trimestre 2025. Le Conseil d'Administration de l'entreprise a déclaré un dividende en espèces de 0,035 $ par action d'actions ordinaires. Le dividende sera versé le 15 mai 2025 aux actionnaires enregistrés au 25 avril 2025.
GE HealthCare Technologies (Nasdaq: GEHC) hat die Zahlung seiner vierteljährlichen Dividende für das erste Quartal 2025 bekannt gegeben. Der Vorstand des Unternehmens hat eine Barausschüttung von $0.035 pro Aktie der Stammaktien beschlossen. Die Dividende wird am 15. Mai 2025 an die Aktionäre ausgezahlt, die am 25. April 2025 registriert sind.
- Regular dividend payment indicates stable cash flow distribution to shareholders
- Low dividend amount of $0.035 per share suggests cash distribution to shareholders
About GE HealthCare Technologies Inc.
GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient’s journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring. We are a
GE HealthCare is proud to be among 2025 Fortune World’s Most Admired Companies™.
Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website https://www.gehealthcare.com for more information.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250327923330/en/
Investor Relations Contact:
Carolynne Borders
+1 631 662 4317
carolynne.borders@gehealthcare.com
Media Contact:
Jennifer Fox
+ 1 414 530 3027
jennifer.R.fox@gehealthcare.com
Source: GE HealthCare Technologies Inc.